Literature DB >> 23100158

Apoptosis initiation of β-ionone in SGC-7901 gastric carcinoma cancer cells via a PI3K-AKT pathway.

Qian Liu1, Hong-Wei Dong, Wen-Guang Sun, Ming Liu, Juan C Ibla, Lian-Xin Liu, John W Parry, Xiao-Hui Han, Ming-Song Li, Jia-Ren Liu.   

Abstract

β-ionone has been shown to hold potent anti-proliferative and apoptosis induction properties in vitro and in vivo. To investigate the effects of β-ionone on apoptosis initiation and its possible mechanisms of action, we qualified cell apoptosis, proteins related to apoptosis and a phosphatidylinositol 3-kinase (PI3K)-AKT pathway in human gastric adenocarcinoma cancer SGC-7901 cells. The results demonstrated that β-ionone-induced apoptosis in a dose-dependent manner in SGC-7901 cells treated with β-ionone (25, 50, 100 and 200 μmol/L) for 24 h. β-ionone was also shown to induce the expression of cleaved-caspase-3 and inhibit bcl-2 expression in SGC-7901 cells in a dose-dependent manner. The significantly decreased levels of p-PI3K and p-AKT expression were observed in SGC-7901 cells after β-ionone treatments in a time- and dose-dependent manner (P < 0.01). Thus, the apoptosis induction in SGC-7901 cells by β-ionone may be regulated through a PI3K-AKT pathway. These results demonstrate a potential mechanism by which β-ionone to induce apoptosis initiation in SGC-7901 cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23100158     DOI: 10.1007/s00204-012-0962-8

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  9 in total

1.  Tocotrienol-rich fraction (TRF) suppresses the growth of human colon cancer xenografts in Balb/C nude mice by the Wnt pathway.

Authors:  Jing-Shu Zhang; Shu-Jing Zhang; Qian Li; Ying-Hua Liu; Ning He; Jing Zhang; Peng-Hui Zhou; Min Li; Tong Guan; Jia-Ren Liu
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

2.  Proteome Changes of Human Bone Marrow Mesenchymal Stem Cells Induced by 1,4-Benzoquinone.

Authors:  Wei Wu; Ling Zhang; Min Zhang; Li-Jin Zhu; Hai-Ling Xia; Jian-Lin Lou; Jia-Ren Liu; Yun Xiao
Journal:  Biomed Res Int       Date:  2016-12-29       Impact factor: 3.411

3.  AKT1-targeted proapoptotic activity of compound K in human breast cancer cells.

Authors:  Eunju Choi; Eunji Kim; Ji Hye Kim; Keejung Yoon; Sunggyu Kim; Jongsung Lee; Jae Youl Cho
Journal:  J Ginseng Res       Date:  2019-07-25       Impact factor: 6.060

Review 4.  Ionone Is More than a Violet's Fragrance: A Review.

Authors:  Lujain Aloum; Eman Alefishat; Abdu Adem; Georg Petroianu
Journal:  Molecules       Date:  2020-12-10       Impact factor: 4.411

5.  Characteristics of NtCCD1-3 from tobacco, and protein engineering of the CCD1 to enhance β -ionone production in yeast.

Authors:  Xiaowei Gong; Fan Li; Yupeng Liang; Xiulin Han; Mengliang Wen
Journal:  Front Microbiol       Date:  2022-09-23       Impact factor: 6.064

6.  The Effective Analysis for Blue Honeysuckle Extract in the Treatment of Hepatocellular Carcinoma.

Authors:  Chun-Peng Zhang; Wei-Hua Li; Jia-Ren Liu; Guo-Dong Li; Hao-Peng Zhang; Jiu-Feng Wei; Hong-Sheng Chen; Jin-Lu Zhao; Yun-Feng Wang; Qiang Lv; Ming Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-29       Impact factor: 2.650

7.  The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma.

Authors:  Tasuku Matsuoka; Masakazu Yashiro
Journal:  Cancers (Basel)       Date:  2014-07-07       Impact factor: 6.639

8.  Anticancer Efficacy of Cordyceps militaris Ethanol Extract in a Xenografted Leukemia Model.

Authors:  Jae Gwang Park; Young-Jin Son; Tae Ho Lee; Nam Joon Baek; Deok Hyo Yoon; Tae Woong Kim; Adithan Aravinthan; Sungyoul Hong; Jong-Hoon Kim; Gi-Ho Sung; Jae Youl Cho
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-06       Impact factor: 2.629

9.  Identification of the lncRNA-miRNA-mRNA network associated with gastric cancer via integrated bioinformatics analysis.

Authors:  Xiao-Yu Ma; Yu Ma; Huan Zhou; Hui-Jing Zhang; Ming-Jun Sun
Journal:  Oncol Lett       Date:  2019-09-25       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.